Crossmark

Pembrolizumab plus cisplatin and fluorouracil as induction chemotherapy followed by definitive chemoradiotherapy for patients with cT4 and/or supraclavicular lymph node metastasis (M1Lym) of esophageal squamous cell carcinoma

Crossref DOI link: https://doi.org/10.1007/s00595-024-02867-1

Published Online: 2024-05-20

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hokamura, Nobukazu https://orcid.org/0000-0002-9717-7464
Fukagawa, Takeo

Fukushima, Ryoji

Kiyokawa, Takashi

Horikawa, Masahiro

Kumata, Yoshimasa

Suzuki, Yusuke

Midorikawa, Hironori
License Information

Text and Data Mining valid from 2024-05-20

Version of Record valid from 2024-05-20
More Information

Article History

Received: 17 January 2024

Accepted: 9 May 2024

First Online: 20 May 2024

Declarations

:

: Nobukazu Hokamura and his co-authors have no conflicts of interest to declare.

: The current study was approved by the Ethics Committee of Teikyo University School of Medicine and performed in accordance with the guidelines approved by The Japan Esophageal Society.

Document is current

Any future updates will be listed below